Massachusetts Institute Of Technology Patent Portfolio Statistics

Massachusetts Institute Of Technology

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Massachusetts Institute Of Technology look like?

Total Applications: 8,355
Granted Patents: 5,216
Grant Index 76.53 %
Abandoned/Rejected Applications: 1,600 (23.47%)
In-Process Applications: 1,515
Average Grant Time: 3.14 Years
Average Office Actions: 1.87

Which Technology Area Massachusetts Institute Of Technology is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 350
1636 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 174
2874 Optics 125
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 113
1633 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 102

How many patents are Massachusetts Institute Of Technology filing every year?

Year Total Applications
2022 0*
2021 212*
2020 460
2019 518
2018 560

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Massachusetts Institute Of Technology in USPTO?

Publication number: US20210386829A1
Application number: 17/052,873

Abstract:
The present invention provides novel compositions and methods based on the discovery of the mechanisms and gene expression programs associated with homeostatic ILC2s and proinflammatory ILC2s that drive tissue inflammation. Molecular cues were identified that modulate ILC responses to alarmins using single-cell RNA-sequencing (scRNA-seq) profiles of lung-resident ILCs at steady state and after in vivo stimulation. The neuropeptide CGRP and the CGRP receptor were identified as expressed on ILC2s. Treatment with CGRP reduces allergic lung inflammation and reduces the proliferation and expansion of ILC2 cells. The results demonstrate that CGRP signaling strongly modulates ILC2 responses and highlights the importance of neuro-immune crosstalk in allergic inflammatory responses at mucosal surfaces.

Publication date: 2021-12-16
Applicant: Massachusetts Institute Of Technology
Inventors: Antonia Wallrapp


Publication number: US20220025463A1
Application number: 17/495,219

Abstract:
The embodiments disclosed herein utilized RNA targeting effectors to provide a robust CRISPR-based diagnostic with attomolar sensitivity. Embodiments disclosed herein can detect both DNA and RNA with comparable levels of sensitivity and can differentiate targets from non-targets based on single base pair differences. Moreover, the embodiments disclosed herein can be prepared in freeze-dried format for convenient distribution and point-of-care (POC) applications. Such embodiments are useful in multiple scenarios in human health including, for example, viral detection, bacterial strain typing, sensitive genotyping, and detection of disease-associated cell free DNA.

Publication date: 2022-01-27
Applicant: Massachusetts Institute Of Technology
Inventors: Gootenberg Jonathan


Publication number: US20220029207A1
Application number: 17/492,952

Abstract:
The present disclosure is generally related to separators for use in lithium metal batteries, and associated systems and products. Certain embodiments are related to separators that form or are repaired when an electrode is held at a voltage. In some embodiments, an electrochemical cell may comprise an electrolyte that comprises a precursor for the separator.

Publication date: 2022-01-27
Applicant: Massachusetts Institute Of Technology
Inventors: Henry William Woodford


How are Massachusetts Institute Of Technology’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/052,873 Compositions And Methods For Modulating Cgrp Signaling To Regulate Innate Lymphoid Cell Inflammatory Responses Application Returned back to Preexam OPAP Central, Docket
17/495,219 Crispr Effector System Based Diagnostics 1636
17/492,952 Lithium Metal Electrodes And Batteries Thereof OPAP Central, Docket
17/492,512 Circular Rna For Translation In Eukaryotic Cells 1632 Chen, Shin Lin
17/489,308 Protected Guide Rnas (Pgrnas) OPAP Central, Docket